[Skip to Navigation]
Comment & Response
September 21, 2020

High-Flow Nasal Cannula as Rescue Therapy in Bronchiolitis

Author Affiliations
  • 1Emergency Department, Perth Children’s Hospital, Nedlands, West Australia, Australia
  • 2Curtin University, Bentley, West Australia, Australia
  • 3Emergency Department, Royal Children's Hospital, University of Melbourne, Parkville, Victoria, Australia
  • 4Emergency Research, Murdoch Children's Research Institute, Parkville, Victoria, Australia
  • 5Children’s Emergency Department, Starship Children’s Hospital, University of Auckland, Auckland, New Zealand
JAMA Pediatr. 2021;175(2):207-208. doi:10.1001/jamapediatrics.2020.2563

To the Editor We read with interest the Viewpoint “High-Flow Nasal Cannula Therapy for Pediatric Patients With Bronchiolitis: Time to Put the Horse Back in the Barn”1 and thank the author for her review that broadly agrees with the Paediatric Research in Emergency Departments International Collaborative (PREDICT) network interpretation that the data from the 2 published randomized clinical trials (RCTs)2,3 support the use of high-flow nasal cannula (HFNC) therapy in infants with hypoxia where standard oxygen therapy has failed.4

Add or change institution